glp 1 agonist drug interactions Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Frontiers | GLP−1 receptor agonists
Description
Read the full publication here: #WeightManagement #ObesityMedicine #WeightLoss #Metabolic #GLP1 #Biotech To view or add a comment, sign in Weight regain after discontinuing #GLP1 therapy is one of the biggest unsolved challenges in obesity care
Together these data support a stronger brain dependence of the body-weight-lowering effects of GLP-1MK-801 compared with semaglutide
doi: 10.1016/j.neurobiolaging.2017.12.009 [DOI] [PubMed] [Google Scholar] 204
3 Future directions Looking ahead, the future of GLP-1 research appears promising
10.1016/j.metabol.2016.03.009 Metabolism 25 FontanellaR.GhoshP.PesapaneA.TaktazF.PuocciA.FranzeseM.et al (2024)
Reduced carbohydrate availability constrains glycolytic flux and increases dependence on lipid-derived substrates
